Innovative Pharmaceutical Biotech P/E 2024

Innovative Pharmaceutical Biotech P/E

-1.19

Innovative Pharmaceutical Biotech Dividend yield

Ticker

399.HK

ISIN

BMG4783W1073

WKN

A1416X

As of May 16, 2024, Innovative Pharmaceutical Biotech's P/E ratio was -1.19, a -119.9% change from the 5.98 P/E ratio recorded in the previous year.

The Innovative Pharmaceutical Biotech P/E history

Innovative Pharmaceutical Biotech Aktienanalyse

What does Innovative Pharmaceutical Biotech do?

The company Innovative Pharmaceutical Biotech Ltd is a company that is active in the field of biotechnological and pharmaceutical research and development. The company has its roots in the research and development of innovative active substances and drugs. The company's history began in the 1990s, when a group of scientists came together to bundle their expertise and visions and develop innovative solutions in the field of active substance research. They founded Innovative Pharmaceutical Biotech Ltd as an independent company in 2000. The company's business model is based on the research and development of new active substances and drugs in the field of oncology, neurology, and immunology. The company follows an insistence-driven approach, aiming to develop active substances with innovative mechanisms of action that are superior to proven therapeutic approaches. Innovative Pharmaceutical Biotech Ltd collaborates with a broad network of partners and cooperation partners, including academic research institutions, clinical centers, biotech companies, and pharmaceutical companies. The company cooperates with companies from all over the world and operates worldwide. The company has various divisions, each focusing on the development of active substances and drugs in specific medical fields. In the oncology division, the company develops active substances and drugs for the treatment of cancer. In the neurology division, active substances and drugs for the treatment of neurological diseases such as Alzheimer's and Parkinson's are researched and developed. The immunology division of the company is dedicated to the development of active substances and drugs for the treatment of immune system diseases such as autoimmune diseases and inflammations. Over the years, the company has developed and launched a number of products. One of its most important products is an active substance for the treatment of breast cancer, which has shown promising results in clinical studies. The company has also developed a treatment for the relief of pain in cancer and other patients based on chemotherapy symptoms. In addition to its research and development efforts, Innovative Pharmaceutical Biotech Ltd attaches great importance to compliance with standards and regulations in the pharmaceutical and biotechnological industry. The company maintains strict quality control procedures and strives to adhere to the highest standards in drug manufacturing. Innovative Pharmaceutical Biotech Ltd sees itself as a pioneer in the pharmaceutical and biotechnological industry and takes pride in developing innovative solutions that have the potential to improve the lives of people around the world. The company has a variety of partners and cooperation partners worldwide and is proud to have a global presence in the field of biotechnological and pharmaceutical research and development. In summary, Innovative Pharmaceutical Biotech Ltd is a company that focuses on the research and development of innovative active substances and drugs that have the potential to improve the lives of people worldwide. The company collaborates with a broad network of partners and cooperation partners and maintains strict quality control procedures to adhere to the highest standards in drug manufacturing. The translation is as accurate as possible. Innovative Pharmaceutical Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Innovative Pharmaceutical Biotech's P/E Ratio

The Price to Earnings (P/E) Ratio of Innovative Pharmaceutical Biotech is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Innovative Pharmaceutical Biotech's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Innovative Pharmaceutical Biotech is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Innovative Pharmaceutical Biotech’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Innovative Pharmaceutical Biotech Stock

What is the price-to-earnings ratio of Innovative Pharmaceutical Biotech?

The price-earnings ratio of Innovative Pharmaceutical Biotech is currently -1.19.

How has the price-earnings ratio of Innovative Pharmaceutical Biotech changed compared to last year?

The price-to-earnings ratio of Innovative Pharmaceutical Biotech has increased by -119.9% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Innovative Pharmaceutical Biotech high compared to other companies?

Yes, the price-to-earnings ratio of Innovative Pharmaceutical Biotech is high compared to other companies.

How does an increase in the price-earnings ratio of Innovative Pharmaceutical Biotech affect the company?

An increase in the price-earnings ratio of Innovative Pharmaceutical Biotech would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Innovative Pharmaceutical Biotech affect the company?

A decrease in the price-earnings ratio of Innovative Pharmaceutical Biotech would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Innovative Pharmaceutical Biotech?

Some factors that influence the price-earnings ratio of Innovative Pharmaceutical Biotech are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Innovative Pharmaceutical Biotech pay?

Over the past 12 months, Innovative Pharmaceutical Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Innovative Pharmaceutical Biotech is expected to pay a dividend of 0 HKD.

What is the dividend yield of Innovative Pharmaceutical Biotech?

The current dividend yield of Innovative Pharmaceutical Biotech is .

When does Innovative Pharmaceutical Biotech pay dividends?

Innovative Pharmaceutical Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Innovative Pharmaceutical Biotech?

Innovative Pharmaceutical Biotech paid dividends every year for the past 0 years.

What is the dividend of Innovative Pharmaceutical Biotech?

For the upcoming 12 months, dividends amounting to 0 HKD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Innovative Pharmaceutical Biotech located?

Innovative Pharmaceutical Biotech is assigned to the 'Industry' sector.

Wann musste ich die Aktien von Innovative Pharmaceutical Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Innovative Pharmaceutical Biotech from 12/31/2003 amounting to 0.02 HKD, you needed to have the stock in your portfolio before the ex-date on 12/10/2003.

When did Innovative Pharmaceutical Biotech pay the last dividend?

The last dividend was paid out on 12/31/2003.

What was the dividend of Innovative Pharmaceutical Biotech in the year 2023?

In the year 2023, Innovative Pharmaceutical Biotech distributed 0 HKD as dividends.

In which currency does Innovative Pharmaceutical Biotech pay out the dividend?

The dividends of Innovative Pharmaceutical Biotech are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Innovative Pharmaceutical Biotech

Our stock analysis for Innovative Pharmaceutical Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innovative Pharmaceutical Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.